"Mehiläinen-konserni on yksi tunnetuimmista ja arvostetuimmista yksityisistä terveys- ja sosiaalipalveluiden tuottajista Suomessa. Yli 100-vuotias Mehiläinen on perinteikäs, mutta nopeasti kehittyvä ja kasvava suunnannäyttäjä alallaan. Palvelemme vuosittain yli miljoonaa asiakasta kaikkialla Suomessa yli 290 toimipisteessämme. Asiakkaitamme ovat yksityiset henkilöt, yritykset, vakuutusyhtiöt sekä julkinen sektori. Toimintaamme ohjaavat vahva arvopohja, korkea ammattitaito ja asiakaslähtöisyys. Mehiläisen asiakaskokemus ja työnantajakuva ovat tutkitusti alan huippua. Haemme yhteistyössä asiakkaidemme kanssa jatkuvasti uusia kokonaisvaltaisia ratkaisuja vastataksemme terveydenhuollon tulevaisuuden haasteisiin."

During the past decade, Mehiläinen Leppävaara conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mehiläinen Leppävaara" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mehiläinen Leppävaara" are "Smoking Cessation" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Dyslipidemic" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Mehiläinen Leppävaara" in a lesser frequency.

Most popular intervention types in "Mehiläinen Leppävaara" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nicotine Replacement Therapy Patch" (2 trials), "bupropion hydrochloride" (2 trials), "varenicline tartrate" (2 trials), "Non-interventional" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mehiläinen Leppävaara" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mehiläinen Leppävaara". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mehiläinen Leppävaara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mehiläinen Leppävaara, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".